1
by Wizemann, Theresa M.
Published 2011
National Academies Press
... sources of adverse-event information. Public Health Effectiveness of the FDA 501(K) Clearance Process...

2
Published 2012
National Academies Press

3
Published 2010
National Academies Press
... should conduct clinical trials to protect the public's health and the health of trial participants...

4
Published 2010
National Academies Press
... should conduct clinical trials to protect the public's health and the health of trial participants...